CASEY CARTER: Open Payments
NPI 1225406077 · ROOSEVELT, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$194 in 10 payments from 6 companies in 2025. Trend: 2023 $496 · 2024 $261 · 2025 $194
Food & beverage: $194
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $93 |
| Verona Pharma, Inc. | 1 | $35 |
| Novo Nordisk Inc | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: VRAYLAR, Ohtuvayre, Rybelsus, Sunosi, JARDIANCE, MOUNJARO, UBRELVY.
Industry payments across UT — which companies pay providers there.
